NATCO completes acquisition of Dash Pharmaceuticals LLC01 January 2022

Saturday January 1, 2022 at 6:24 pm

Dash is a front-end pharmaceutical sales, marketing and distribution entity in the USA which is expected to have Net Sales of approximately USD 15 million for the financial year ending December 2021.

This acquisition provides NATCO with a platform to engage with its customers directly in the USA which is the largest pharmaceutical market in the world

Releted Blog
  • Benefits of High-Intensity Interval Training workout

    In the realm of fitness, High-Intensity Interval Training (HIIT) has emerged as a revolutionary approach to exercise. This intense yet time-efficient ...

  • Everything Around Mental Wellness

    Introduction In today's fast-paced and demanding world, mental health has emerged as a critical aspect of overall well-being. The stigma surrounding ...

  • Health Benefits of Resistance Training

    In the pursuit of a healthier and more fulfilling life, exercise plays a pivotal role. Among the diverse forms of exercise, resistance training stands...